[Current broncholytic and expectorant therapy of patients with chronic nonspecific lung diseases].
Correction of the obstructive syndrome in patients with chronic nonspecific pulmonary diseases using modern broncholytics and expectorants is considered. The chief mechanisms of the formation of the obstructive syndrome (bronchospastic and obturation ones as a result of mucociliary transport disorder) are described. The authors propose a scheme of differential clinical and laboratory diagnosis of the above mechanisms of bronchial permeability disorder. Modern broncholytics and expectorants are characterized, mechanisms of their action and practical aspects of their application in chronic nonspecific pulmonary diseases are discussed.
Solopov
V N
VN
Kolganova
N A
NA
Chuchalin
A G
AG
D000336:Aerosols; D001993:Bronchodilator Agents / Q000627:therapeutic use*; D004338:Drug Combinations / Q000627:therapeutic use; D005100:Expectorants / Q000627:therapeutic use*; D005280:Fenoterol / Q000627:therapeutic use; D006801:Humans; D009241:Ipratropium / Q000627:therapeutic use; D008173:Lung Diseases, Obstructive / Q000175:diagnosis / Q000188:drug therapy*; D013806:Theophylline / Q000627:therapeutic use
D000336:Aerosols; D001993:Bronchodilator Agents; D004338:Drug Combinations; D005100:Expectorants; C030809:fenoterol, ipratropium drug combination; D005280:Fenoterol; D013806:Theophylline; D009241:Ipratropium
Sovremennaia bronkholiticheskaia i otkharkivaiushchaia terapiia u bol'nykh khronicheskimi nespetsificheskimi zabolevaniiami legkikh.